Terms: = Colorectal cancer AND NTRK3, TRKC, 4916, ENSG00000140538, Q16288, gp145 trkC AND Diagnosis
4 results:
1. Neurotrophic tyrosine receptor kinase gene fusions in adult and pediatric patients with solid tumors: a clinicogenomic biobank and record linkage study of expression frequency and patient characteristics from Finland.
Zhang W; Schmitz AA; Kallionpää RE; Perälä M; Pitkänen N; Tukiainen M; Alanne E; Jöhrens K; Schulze-Rath R; Farahmand B; Zong J
Acta Oncol; 2024 Jul; 63():542-551. PubMed ID: 38967220
[TBL] [Abstract] [Full Text] [Related]
2. Clinical characteristics and treatment patterns of patients with
Willis C; Au T; Hejazi A; Griswold C; Schabath MB; Thompson J; Malhotra J; Federman N; Ko G; Appukkuttan S; Warnock N; Kong SX; Hocum B; Brixner D; Stenehjem D
J Manag Care Spec Pharm; 2024 Jul; 30(7):672-683. PubMed ID: 38950155
[TBL] [Abstract] [Full Text] [Related]
3. Performances of the Idylla GeneFusion Assay: contribution to a rapid diagnosis of targetable gene fusions in tumour samples.
Guillard M; Caumont C; Marcorelles P; Merlio JP; Cappellen D; Uguen A
J Clin Pathol; 2024 Jul; 77(8):561-567. PubMed ID: 37185257
[TBL] [Abstract] [Full Text] [Related]
4. MSI-High RAS-BRAF wild-type colorectal adenocarcinomas with MLH1 loss have a high frequency of targetable oncogenic gene fusions whose diagnoses are feasible using methods easy-to-implement in pathology laboratories.
Bocciarelli C; Caumont C; Samaison L; Cariou M; Aline-Fardin A; Doucet L; Roudié J; Terris B; Merlio JP; Marcorelles P; Cappellen D; Uguen A
Hum Pathol; 2021 Aug; 114():99-109. PubMed ID: 34019865
[TBL] [Abstract] [Full Text] [Related]